Story thread · 2 reports / 2 sources
A ‘living GLP-1 drug’ could revolutionize diabetes treatment
newatlas.com · 2h
How the coverage leans
Across 2 sources · syndicated copies counted once
Bacteria engineered to sense and reduce glucose levels could be the future of type 2 diabetes treatments, following pre-clinical trials on animal models. Continue Reading Category: Diabetes , Illnesses and conditions , Body and Mind , Refractor: Science & Health Tags: Type 2 diabetes , GLP-1 receptor agonists , Weight Loss , Probiotic , Diet
First report: HHS ‘actively reviewing’ Mike Lee’s push for a new Type 1 diabetes treatment — deseret.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.